{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:57Z","timestamp":1787020797590,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Long non-coding RNA (LncRNA) TUG1 plays critical roles in the\ndevelopment of human cancers. Its inhibition has been proved to participate in\nankylosing spondylitis, which is an inverse pathological procedure of\nosteoporosis. In the present study, we aim to investigate the role of lncRNA\nTUG1 in ankylosing spondylitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Expressions of lncRNA TUG1 in plasma of 98 patients with\nosteoporosis and 60 healthy participants were detected by real-time quantitative\nPCR (RT-qPCR). Diagnostic values of lncRNA CASC11 for osteoclasts were performed\nby the ROC curve with osteoporosis patients as positive and healthy participants\nas negative. All experiments were repeated 3 times. Mean \u00b1 standard deviation\nwas calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that plasma lncRNA TUG1 was upregulated in osteoporosis\npatients than in healthy participants. Upregulation of plasma lncRNA TUG1\ndistinguished osteoporosis patients from healthy participants. LncRNA TUG1 level\nincreased with the advances of clinical stages. Over-expression of lncRNA TUG1\npromoted the proliferation and inhibited the apoptosis of mice osteoclasts,\nwhile lncRNA TUG1 siRNA silencing played an opposite role. In addition, lncRNA\nTUG1 over-expression led to downregulated PTEN, while lncRNA TUG1 siRNA\nsilencing played an opposite role.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Therefore, lncRNA TUG1 is upregulated in osteoporosis and regulates\nthe proliferation and apoptosis of osteoclasts. lncRNA TUG1 knockdown may serve\nas a promising therapeutic target for osteoporosis by inhibiting the\nproliferation and promoting the apoptosis of osteoclasts through PTEN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13018-019-1430-4","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T10:03:13Z","timestamp":1575885793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["RETRACTED ARTICLE: LncRNA TUG1 was upregulated in osteoporosis\nand regulates the proliferation and apoptosis of osteoclasts"],"prefix":"10.1186","volume":"14","author":[{"given":"Ye","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaosong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0144-4618","authenticated-orcid":false,"given":"Xi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"publisher","first-page":"s92","DOI":"10.7861\/clinmedicine.15-6-s92","volume":"15","author":"EM Curtis","year":"2015","unstructured":"Curtis EM, Moon RJ, Dennison EM, Harvey NC, Cooper C. Recent\nadvances in the pathogenesis and treatment of osteoporosis. Clin Med (Lond).\n2015;15:s92\u20136.","journal-title":"Clin Med (Lond)"},{"issue":"8","key":"1430_CR2","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","volume":"37","author":"MT Drake","year":"2015","unstructured":"Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment\nof osteoporosis. Clin Ther. 2015;37(8):1837\u201350.","journal-title":"Clin Ther"},{"key":"1430_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","volume":"5","author":"S Khosla","year":"2017","unstructured":"Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments\nand ongoing challenges. Lancet Diabetes Endocrinol.\n2017;5:898\u2013907.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1430_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/jwh.2013.4611","volume":"23","author":"JM Kling","year":"2014","unstructured":"Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening,\nand treatment: a review. J Womens Health (Larchmt).\n2014;23:563\u201372.","journal-title":"J Womens Health (Larchmt)"},{"key":"1430_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY. Unique features of long non-coding RNA\nbiogenesis and function. Nat Rev Genet. 2016;17:47\u201362.","journal-title":"Nat Rev Genet"},{"key":"1430_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tcb.2011.04.001","volume":"21","author":"O Wapinski","year":"2011","unstructured":"Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends\nCell Biol. 2011;21:354\u201361.","journal-title":"Trends Cell Biol"},{"key":"1430_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3892\/ijmm.2017.3062","volume":"40","author":"L Hao","year":"2017","unstructured":"Hao L, Fu J, Tian Y, Wu J. Systematic analysis of lncRNAs, miRNAs\nand mRNAs for the identification of biomarkers for osteoporosis in the mandible\nof ovariectomized mice. Int J Mol Med. 2017;40:689\u2013702.","journal-title":"Int J Mol Med"},{"key":"1430_CR8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/1535370215622708","volume":"241","author":"J Li","year":"2016","unstructured":"Li J, Zhang M, An G, Ma Q. LncRNA TUG1 acts as a tumor suppressor\nin human glioma by promoting cell apoptosis. Exp Biol Med (Maywood).\n2016;241:644\u20139.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1430_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.gene.2017.01.024","volume":"608","author":"S Liang","year":"2017","unstructured":"Liang S, Zhang S, Wang P, Yang C, Shang C, et al. LncRNA, TUG1\nregulates the oral squamous cell carcinoma progression possibly via interacting\nwith Wnt\/\u03b2-catenin signaling. Gene. 2017;608:49\u201357.","journal-title":"Gene"},{"key":"1430_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5582\/bst.2018.01117","volume":"12","author":"X Lan","year":"2018","unstructured":"Lan X, Ma H, Zhang Z, Ye D, Ma J, et al. Down-regulation of lncRNA\nTUG1 is involved in ankylosing spondylitis and is related to disease activity\nand course of treatment. Biosci Trends. 2018;12:389\u201394.","journal-title":"Biosci Trends"},{"key":"1430_CR11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/jbmr.2084","volume":"29","author":"V Stiffel","year":"2014","unstructured":"Stiffel V, Amoui M, Sheng MH, Mohan S, Lau KH. EphA4 receptor is a\nnovel negative regulator of osteoclast activity. J Bone Miner Res.\n2014;29:804\u201319.","journal-title":"J Bone Miner Res"},{"key":"1430_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.biopha.2017.02.090","volume":"89","author":"Q Wang","year":"2017","unstructured":"Wang Q, Li Y, Zhang Y, Ma L, Lin L, et al. LncRNA MEG3 inhibited\nosteogenic differentiation of bone marrow mesenchymal stem cells from\npostmenopausal osteoporosis by targeting miR-133a-3p. Biomed Pharmacother.\n2017;89:1178\u201386.","journal-title":"Biomed Pharmacother"},{"key":"1430_CR13","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/09168451.2014.998617","volume":"79","author":"X Tong","year":"2015","unstructured":"Tong X, Gu P, Xu S, Lin XJ. Long non-coding RNA-DANCR in human\ncirculating monocytes: a potential biomarker associated with postmenopausal\nosteoporosis. Biosci Biotechnol Biochem. 2015;79:732\u20137.","journal-title":"Biosci Biotechnol Biochem"},{"key":"1430_CR14","doi-asserted-by":"crossref","unstructured":"Zhang N, Hu X, He S, et al. LncRNA MSC-AS1 promotes osteogenic\ndifferentiation and alleviates osteoporosis through sponging microRNA-140\u20135p to\nup-regulate BMP2[J]. Biochem Biophys Res Commun. 2019 21. pii:\nS0006-291X(19)31779-6","DOI":"10.1016\/j.bbrc.2019.09.058"},{"issue":"11","key":"1430_CR15","first-page":"4609","volume":"23","author":"S Zheng","year":"2019","unstructured":"Zheng S, Wang YB, Yang YL, et al. LncRNA MALAT1 inhibits osteogenic\ndifferentiation of mesenchymal stem cells in osteoporosis rats through MAPK\nsignaling pathway[J]. Eur Rev Med Pharmacol Sci.\n2019;23(11):4609\u201317.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"1430_CR16","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.12659\/MSM.897072","volume":"16","author":"H Zhai","year":"2016","unstructured":"Zhai H, Sui M, Yu X, Qu Z, Hu JC, et al. Over-expression of long\nnon-coding RNA TUG1 promotes colon cancer progression. Med Sci Monit.\n2016;16:3281\u20137.","journal-title":"Med Sci Monit"},{"key":"1430_CR17","first-page":"615486","volume":"20","author":"SA Hienz","year":"2015","unstructured":"Hienz SA, Paliwal S, Ivanovski S. Mechanisms of bone resorption in\nperiodontitis. J Immunol Res. 2015;20:615486.","journal-title":"J Immunol Res"},{"key":"1430_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00198-002-1340-9","volume":"14","author":"E Seeman","year":"2003","unstructured":"Seeman E. Reduced bone formation and increased bone resorption:\nrational targets for the treatment of osteoporosis. Osteoporos Int.\n2003;14:2\u20138.","journal-title":"Osteoporos Int"},{"key":"1430_CR19","first-page":"5815","volume":"22","author":"W Li","year":"2018","unstructured":"Li W, Zhu HM, Xu HD, Zhang B, Huang SM. CRNDE impacts the\nproliferation of osteoclast by estrogen deficiency in postmenopausal\nosteoporosis. Eur Rev Med Pharmacol Sci. 2018;22:5815\u201321.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1430_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000431091","volume":"62","author":"P Pietschmann","year":"2016","unstructured":"Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Foger-Samwald\nU, Ellinger I. Immunology of osteoporosis: a mini-review. Gerontology.\n2016;62:128\u201337.","journal-title":"Gerontology"},{"key":"1430_CR21","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1159\/000491539","volume":"47","author":"Y Wang","year":"2018","unstructured":"Wang Y, Luo TB, Liu L, Cui ZQ. LncRNA LINC00311 promotes the\nproliferation and differentiation of osteoclasts in osteoporotic rats through\nthe notch signaling pathway by targeting DLL3. Cell Physiol Biochem.\n2018;47:2291\u2013306.","journal-title":"Cell Physiol Biochem"},{"key":"1430_CR22","doi-asserted-by":"crossref","unstructured":"Nielsen-Preiss S M, Silva S R, Gillette J M. Role of PTEN and Akt\nin the regulation of growth and apoptosis in human osteoblastic cells. J Cell\nBiochem. 2003, 90(5): 964-975.","DOI":"10.1002\/jcb.10709"},{"issue":"1","key":"1430_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/cvr\/cvx180","volume":"114","author":"C Yu","year":"2017","unstructured":"Yu C, Li L, Xie F, et al. LncRNA TUG1 sponges miR-204-5p to promote\nosteoblast differentiation through up-regulating Runx2 in aortic valve\ncalcification. Cardiovasc Res. 2017, 114(1): 168\u2013179.","journal-title":"Cardiovasc Res"},{"key":"1430_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.biopha.2018.01.040","volume":"99","author":"K Li","year":"2018","unstructured":"Li K, Zhang X, He B, et al. Geraniin promotes osteoblast\nproliferation and differentiation via the activation of Wnt\/\u03b2-catenin pathway.\nBiomed Pharmacother. 2018;99:319\u201324.","journal-title":"Biomed Pharmacother."},{"issue":"4","key":"1430_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/jbmr.2379","volume":"30","author":"X Qin","year":"2015","unstructured":"Qin X, Jiang Q, Matsuo Y, et al. Cbfb regulates bone development by\nstabilizing Runx family proteins. J Bone Miner Res.\n2015;30(4):706\u201314.","journal-title":"J Bone Miner Res."}],"updated-by":[{"DOI":"10.1186\/s13018-020-02000-1","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"record-id":"24391"},{"DOI":"10.1186\/s13018-020-02000-1","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000}}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-019-1430-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13018-019-1430-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-019-1430-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T19:54:29Z","timestamp":1607370869000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-019-1430-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1186\/s13018-019-1430-4","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13018-020-02000-1","URL":"https:\/\/doi.org\/10.1186\/s13018-020-02000-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":".","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Ethics Committee of the\nMaternity and Child Care Center of Liuzhou. The research has been carried out in\naccordance with the World Medical Association Declaration of Helsinki. All\npatients and healthy volunteers provided written informed consent prior to their\ninclusion within the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"416"}}